Article · 2016
Mini reviewPublished 2015
Belimumab: Present and future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Belimumab, a B lymphocyte stimulator (BLyS) inhibitor, recently approved for patients with active, autoantibody-positive systemic lupus erythematosus (SLE) has paved the way for newer drugs that could arrest the complex autoimmune process and reverse the disease pathology. However, there is a need to further delineate long term effects of belimumab on disease activity and progression in patients with lupus nephritis, pregnancy and paediatric populations. Here, we review the on-going clinical trials and registry studies of belimumab in different populations that could define its role in the SLE armamentarium.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2016
Treatment of SLE and Secondary Sjogren’s Syndrome with Belimumab
Perspective · 19 Apr 2022
Note on Belimumab in Treatment of Lupus Nephritis
Other · 22 Jul 2016
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Review article · 8 Jul 2016
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
More from this journal
The newest in Journal of Autoimmune Disorders.
Perspective · 28 Feb 2025
Autoimmune Disorders and Aging: Mechanistic Insights and Clinical Challenges
Commentary · 28 Feb 2025
Nanomedicine in the Diagnosis and Treatment of Autoimmune Disorders
Short communication · 28 Feb 2025
Immune Checkpoints and Their Dysregulation in Autoimmunity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Autoimmune Disorders
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “CD Tripathi”
- BylineArticles whose byline prints “Preeta Kaur Chugh”

